Patents by Inventor Raphaelle Bourdet-Sicard

Raphaelle Bourdet-Sicard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Reuterin-producing
    Patent number: 9387229
    Abstract: The invention relates to reuterin-producing strains of Lactobacillus brevis. These strains are useful in particular for the treatment or the prevention of conditions resulting from Helicobacter pylori infection.
    Type: Grant
    Filed: November 30, 2011
    Date of Patent: July 12, 2016
    Assignee: Compagnie Gervais Danone
    Inventors: Peggy Garault, Gaelle Quere, Raphaelle Bourdet-Sicard
  • Strain of capable of inhibiting the adhesion of strains to epithelial cells
    Patent number: 9272007
    Abstract: The present invention relates to a new strain of Lactobacillus delbrueckii subsp. bulgaricus, suitable for use in the treatment or prevention of Helicobacter pylori infection.
    Type: Grant
    Filed: August 9, 2011
    Date of Patent: March 1, 2016
    Assignee: Compagnie Gervais Danone
    Inventors: Peggy Garault, Gaelle Quere, Raphaelle Bourdet-Sicard, Francis Megraud
  • STREPTOCOCCUS THERMOPHILUS STRAINS FOR TREATING HELICOBACTER PYLORI INFECTION
    Publication number: 20150284675
    Abstract: The present invention relates to a strain of Streptococcus thermophilus or a cell fraction thereof for use in the treatment or prevention of Helicobacter pylori infection.
    Type: Application
    Filed: October 25, 2012
    Publication date: October 8, 2015
    Inventors: Peggy Garault, Raphaelle Bourdet-Sicard, Francis Megroud
  • Reuterin-Producing Lactobacillus Brevis
    Publication number: 20140341855
    Abstract: The invention relates to reuterin-producing strains of Lactobacillus brevis. These strains are useful in particular for the treatment or the prevention of conditions resulting from Helicobacter pylori infection.
    Type: Application
    Filed: November 30, 2011
    Publication date: November 20, 2014
    Applicant: COMPAGNIE GERVAIS DANONE
    Inventors: Peggy Garault, Gaelle Quere, Raphaelle Bourdet-Sicard
  • Strain of L. Bulgaricus Capable of Inhibiting the Adhesion of H. Pylori Strains to Epithelial Cells
    Publication number: 20140205571
    Abstract: The present invention relates to a new strain of Lactobacillus delbrueckii subsp. bulgaricus, suitable for use in the treatment or prevention of Helicobacter pylori infection.
    Type: Application
    Filed: August 9, 2011
    Publication date: July 24, 2014
    Applicant: COMPAGNIE GERVAIS DANONE
    Inventors: Peggy Garault, Gaelle Quere, Raphaelle Bourdet-Sicard, Francis Megraud
  • Method for selecting bacteria with anti-oxidant action
    Patent number: 8735089
    Abstract: The present invention relates to a method using Caenorhabditis elegans for screening of food grade bacteria which have a protective effect against oxidative stress.
    Type: Grant
    Filed: January 8, 2010
    Date of Patent: May 27, 2014
    Assignees: Compagnie Gervais Danone, Biopolis S.L.
    Inventors: Gianfranco Grompone, Marie-Christine Degivry, Daniel Ramon Vidal, Patricia Martorell Guerola, Nuria Gonzalez Martinez, Salvador Genoves Martinez, Sophie Legrain-Raspaud, Isabelle Chambaud, Raphaelle Bourdet-Sicard
  • Method for Selecting Bacteria with Anti-Oxidant Action
    Publication number: 20130078187
    Abstract: The present invention relates to a method using Caenorhabditis elegans for screening of food grade bacteria which have a protective effect against oxidative stress.
    Type: Application
    Filed: January 8, 2010
    Publication date: March 28, 2013
    Inventors: Gianfranco Grompone, Marie-Christine Degivry, Daniel Ramon Vidal, Patricia Martorell Guerola, Nuria Gonzalez Martinez, Salvador Genoves Martinez, Sophie Legrain-Raspaud, Isabelle Chambaud, Raphaelle Bourdet-Sicard
  • Use of Lactobacillus casei for Increasing the Protection Provided by the Influenza Vaccine
    Publication number: 20100129334
    Abstract: The invention relates to the use of Lactobacillus casei in orally administrable compositions for increasing protection against influenza after the influenza vaccine, by potentiating the humoral response generated by said vaccine.
    Type: Application
    Filed: February 13, 2008
    Publication date: May 27, 2010
    Applicant: COMPAGNIE GERVAIS DANONE
    Inventors: Sandrine Samson-Villeger, Raphaelle Bourdet-Sicard
  • Use of a Fermented Milk Containing L. Casei for the Manufacture of a Composition for the Prevention or Treatment of a Delayed-Type Hypersensitivity Reaction
    Publication number: 20090068149
    Abstract: The present invention relates to the field of probiotics. More particularly, the invention pertains to the use of a particular strain, Lactobacillus casei CNCM I-1518, which is present in Actimel®, for alleviating the symptoms of a delayed-type hypersensitivity reaction.
    Type: Application
    Filed: January 20, 2006
    Publication date: March 12, 2009
    Inventors: Jean Francois Nicolas, Catherine Goujon, Raphaelle Bourdet-Sicard, Nathalie Rolf-Pedersen